Avalon Pharma shares steady awaiting key levels
The share of Al Sharq Middle East Pharmaceuticals "Avalon Pharma" has been moving sideways since April 2026, with a temporary pause at key support and resistance levels between 56.65 and 64.40 SAR. Technical indicators show that the stock is gradually gaining momentum, with rising lows and increasing trading volume, which enhances the likelihood of breaking through resistance and reaching levels of 65.85 SAR and then 67.60 SAR, especially if it stabilizes above 64.40 SAR. Continued sideways movement while maintaining 64.40 SAR as a major support level keeps the negative scenario intact, with close monitoring of the 56.65 SAR level necessary to support future expectations for the stock.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)